Small Cap Breaking News You Can’t Miss!
Here’s a quick rundown of the latest updates from standout small-cap companies making big moves today.
Quantum BioPharma (CSE: QNTM) — Strengthening MS Trial Firepower
Quantum appointed world-renowned MS clinician Dr. Jack Antel to advise on efficacy trial design for Lucid-MS, its investigational, neuroprotective MS therapy. The hire adds top-tier clinical guidance as the company advances from early safety into Phase 2 planning, aiming to align endpoints, biomarkers, and site strategy with best-in-class MS standards.
Prospector Metals (TSXV: PPP) — High-Grade Discovery in Yukon
At the ML Project, new “TESS Zone” drilling returned a standout 44 m @ 13.79 g/t gold and 1.84% copper from 62 m, including 24.65 m @ 21.93 g/t gold (with 1 m @ 288 g/t). The zone is traced on surface for ~500 m and remains open, while only 12 of 39 holes from 2025 have reported—leaving room for scale as follow-up drilling targets multiple look-alike structures.
Brixton Metals (TSXV: BBB) — Near-Surface Growth at Trapper
Fresh results at the Thorn Project’s Trapper Target include 15.0 m @ 2.26 g/t gold from 16.0 m (THN25-339) and 6.4 m @ 4.61 g/t from 27.1 m (THN25-337). Drilling extended mineralization 36 m to the south-southwest where it stays open; 18 of 30 holes still pending—several with visible gold—set up the next read on scale and continuity.
Blue Star Gold (TSXV: BAU) — Nutaaq Trend Extends to 1.6 km
Initial 2025 drilling in Nunavut delivered 5.70 m @ 7.31 g/t gold (incl. 1.80 m @ 21.1 g/t) plus 2.79 m @ 4.33 g/t and 7.97 m @ 1.40 g/t in hole 25UND-002. The Nutaaq footprint expanded ~335 m WNW of Gnu Zone; selective surface grabs up to 115.5 g/t along parallel trends highlight targets for a robust 2026 drill program.
—
For more breaking small-cap news and real-time updates, follow AGORACOM across our channels—and don’t miss our podcast for deep dives and CEO interviews.